Search results for Novartis Pharmaceuticals - Clinical Trials Registry

Example: Heart Attack

Clinical Trials Sponsored by Novartis Pharmaceuticals

Total 2737 results

NCT05526729

Recruiting

Special Drug Use Observational Study With Beovu Kit for Intravitreal Injection

Conditions: Diabetic Macular Edema
NCT05462873

Recruiting

A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors

Conditions: Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Esophageal Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck
NCT05360446

Recruiting

Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events

Conditions: Coronary Artery Disease
NCT05344469

Recruiting

A NIS Evaluating Injectable Treatments in Patients With Relapsing Multiple Sclerosis

Conditions: Relapsing Multiple Sclerosis
NCT05334472

Recruiting

A Survey to Evaluate Early Experience From Patient and Care Partner on Injection and Device for KESIMPTA® Indicated for Multiple Sclerosis

Conditions: Multiple Sclerosis
NCT05397496

Recruiting

Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies

Conditions: B-cell Non-Hodgkin Lymphoma (B-NHL), B-cell Acute Lymphoblastic Leukemia (B-ALL)
NCT02278120

Active, not recruiting

Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer

Conditions: Advanced Metastatic Breast Cancer
NCT04774003

Completed

Study of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inclisiran in Chinese Participants With Elevated Serum LDL-C

Conditions: Hyperlipidemia
NCT02445248

Completed

Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients

Conditions: Diffuse Large B-cell Lymphoma (DLBCL)
NCT03876028

Terminated

Study of Tisagenlecleucel in Combination With Ibrutinib in r/r Diffuse Large B-cell Lymphoma Patients

Conditions: Diffuse Large B-cell Lymphoma
NCT05524051

Recruiting

A Multi-center Study to Evaluate the Safety, Tolerability and Efficacy of TIN816 in Patients at Risk for Acute Kidney Injury Following Cardiac Surgery.

Conditions: Acute Kidney Injury Following Cardiac Surgery
NCT05467891

Recruiting

Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

Conditions: Locoregional Recurrence, Hormone Receptor-positive Breast Cancer, HER2-negative Breast Cancer
NCT05460533

Recruiting

A Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Lymphoma (B-ALL)

Conditions: B-cell Acute Lymphoblastic Leukemia
NCT05429502

Recruiting

Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors

Conditions: Neuroblastoma
NCT04948333

Recruiting

Asciminib Treatment Optimization in ≥ 3rd Line CML-CP.

Conditions: Chronic Myelogenous Leukemia
NCT04935359

Recruiting

Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - daNIS-2

Conditions: Metastatic Pancreatic Ductal Adenocarcinoma
NCT04877522

Recruiting

Asciminib Roll-over Study

Conditions: Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive
NCT04677595

Recruiting

Study of Capmatinib in Chinese Adult Patients With Advanced Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation

Conditions: Non-Small Cell Lung Cancer (NSCLC)
NCT04524000

Recruiting

Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast Cancer

Conditions: Advanced Breast Cancer
NCT04452877

Recruiting

A Study of Dabrafenib in Combination With Trametinib in Chinese Patients With BRAF V600E Mutant Metastatic NSCLC

Conditions: Carcinoma, Non-Small-Cell Lung
NCT03975829

Recruiting

Pediatric Long-Term Follow-up and Rollover Study

Conditions: Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma, Oligodendroglioma, Childhood, Anaplastic Oligodendroglioma, Glioblastoma, Pilocytic Astrocytoma, Giant Cell Astrocytoma, Pleomorphic Xanthoastrocytoma, Anaplastic Pleomorphic Xanthoastrocytoma, Angiocentric Glioma, Chordoid Glioma of Third Ventricle, Gangliocytoma, Ganglioglioma, Anaplastic Ganglioglioma, Dysplastic Gangliocytoma of Cerebrellum, Desmoplastic Infantile Astrocytoma and Ganglioglioma, Papillary Glioneuronal Tumor, Rosette-forming Glioneurona Tumor, Central Neurocytoma, Extraventricular Neurocytoma, Cerebellar Liponeurocytoma, Neurofibromatosis Type 1
NCT03040973

Recruiting

Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone

Conditions: Advanced Solid Tumors Which Are cMET-dependent
NCT05703516

Not yet recruiting

A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea

Conditions: Non-Small-Cell Lung Carcinoma
NCT05199090

Active, not recruiting

Study to Assess Safety, Tolerability and Efficacy of SC Administered MBL949 in Obese Participants With or Without T2DM

Conditions: Obesity
NCT02684058

Active, not recruiting

Phase II Pediatric Study With Dabrafenib in Combination With Trametinib in Patients With HGG and LGG

Conditions: Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma, Oligodendroglioma, Childhood, Anaplastic Oligodendroglioma, Glioblastoma, Pilocytic Astrocytoma, Giant Cell Astrocytoma, Pleomorphic Xanthoastrocytoma, Anaplastic Pleomorphic Xanthoastrocytoma, Angiocentric Glioma, Chordoid Glioma of Third Ventricle, Gangliocytoma, Ganglioglioma, Anaplastic Ganglioglioma, Dysplastic Gangliocytoma of Cerebrellum, Desmoplastic Infantile Astrocytoma and Ganglioglioma, Papillary Glioneuronal Tumor, Rosette-forming Glioneurona Tumor, Central Neurocytoma, Extraventricular Neurocytoma, Cerebellar Iponeurocytoma

Clinical Trials Sponsored by Novartis Pharmaceuticals

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations